Why Is Warren Piling Into This Monster Insurer?
Imagine a business that has quietly dominated its industry for decades, steadily outperforming its rivals while keeping an impeccable balance sheet.
Add to the fact that it has thrived during economic downturns and periods of rising interest rates when its peers faded.
In recent years, it’s seen its earnings surge, boosted by both disciplined underwriting and a strong investment portfolio. » Read more about: Why Is Warren Piling Into This Monster Insurer? »
Read More
Alert: Get Pharma Royalties Plus 58.1% Upside
Investment Alert: Buy Royalty Pharma (RPRX) Under $33/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
How would you like a cut of those lucrative pharmaceutical royalties that famously mint money?
» Read more about: Alert: Get Pharma Royalties Plus 58.1% Upside »
Read More
Alert: 27.6% Upside in Technical Breakout?
Investment Alert: Buy BYND Under $13.10/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Usually we like to find fundamentally undervalued stocks that have a proven track record of growing through thick and thin.
» Read more about: Alert: 27.6% Upside in Technical Breakout? »
Read More
Alert: Billionaire Owns Under-the-Radar Stock with 48.7% Upside
Investment Alert: Buy EPAM Under $210/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
Read More
Billionaire Bets The Farm On Under-the-Radar Health Stock
Stanley Druckenmiller is among the most astute stock pickers in the world and often ahead of broader market consensus. That may be attributable to his view that it’s best to buy with an eye on where things will be in 18 months versus today.
One of his latest buys, and a big one at that,
» Read more about: Billionaire Bets The Farm On Under-the-Radar Health Stock »
Read MoreThe Burst
1 Wild Stat Since 1990 Is Ominous
The market is much like a pendulum, swinging back and forth, or more precisely up and down. With each dip, it finds the energy to power higher to break new highs. Until the buyers are exhausted that is, and then a correction follows.
Usually, it climbs up steps, slowly and methodically, but falls down the elevator shaft.
» Read more about: 1 Wild Stat Since 1990 Is Ominous »
Read MoreThe Spotlight
Spotlight: Should Sweetgreen Be 50% Higher?
CAVA debuted on the New York Stock Exchange on June 16, selling 14.4 million shares and raising a cash hoard of $318 million at a valuation just under $2.5 billion.
Eagle-eyed investors were stunned to see the share price soar by as much as 117%, before ultimately closing at $43.78 per share, slightly above its $42 open.
» Read more about: Spotlight: Should Sweetgreen Be 50% Higher? »
Read MoreThe Daily
Davis Commodities Eyes USD 100M Revenue Surge in Sugar Trading Amid Global Market Expansion
SINGAPORE, June 23, 2025 (GLOBE NEWSWIRE) — Davis Commodities Limited (Nasdaq: DTCK), a premier Singapore-based trader of agricultural commodities, has announced an ambitious expansion across Africa, Asia, and the Middle East, driven by surging global demand for sugar and rice. Supported by its recently secured USD 30 million capital raise,